Molecular biology of red cell blood group genes

Transfusion

Volumn 32, Issue 5, 1992, Pages 467-483

  Lutz, P ^a   Dzik, W H ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN; GLYCOPHORIN A;

BLOOD GROUP; COOMBS TEST; CYTOPLASM; DNA SEQUENCE; ERYTHROCYTE; EUKARYOTIC CELL; GENETIC CODE; GENETIC TRANSCRIPTION; HUMAN; MOLECULAR BIOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RNA SPLICING; RNA TRANSLATION;

AMINO ACID SEQUENCE; BASE SEQUENCE; BLOOD GROUPS; GENETIC CODE; HUMAN; PHENOTYPE; RNA SPLICING;

EID: 0026696310     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1992.32592327723.x     Document Type: Review

References (69)

1. Blood group‐active surface molecules of the human red blood cell
2. Regulator genes affecting red cell antigens
3. Human red cell glycophorins: biochemical and antigenic properties
4. Localisation of the human ABO:Np‐1:AK‐1 linkage group by regional assignment of AK‐1 to 9q34
5. Isolation to homogeneity and partial characterization of a histo‐blood group A defined Fucα1→2Galα1→3‐N‐acetylgalactosaminyltransferase from human lung tissue
6. Cloning and characterization of DNA complementary to human UDP‐Fucα1→2Galα1→3GalNAc transferase (histo‐blood group A transferase) mRNA
7. Primary structure of β‐galactoside α2, 6‐sialyltransferase. Conversion of membrane‐bound enzyme to soluble forms by cleavage of the NH2‐terminal signal anchor
8. Characterization of the full length cDNA for murine β‐1,4‐galactosyl‐transferase. Novel features at the 5′‐end predict two translational start sites at two in‐frame AUGs
9. Molecular genetic basis of the histo‐blood group ABO system
10. Purification of H gene‐encoded β‐galactoside α1→2 fucosyltransferase from human serum
11. Stable expression of blood group H determinants and GDP‐L‐fucose: β‐D‐galactoside 2‐α‐L‐fucosyltransferase in mouse cells after transfection with human DNA
12. Molecular cloning, sequence, and expression of a human GDP‐L‐fucose:β‐D‐galactoside 2‐α‐L‐fucosyltransferase cDNA that can form the H blood group antigen
13. Somatic cell genetic assignment of peptidase C and the Rh linkage group to chromosome A‐1 in man
14. Molecular cloning and protein structure of a human blood group Rh polypeptide
15. cDNA cloning of a 30 kDa erythrocyte membrane protein associated with Rh (Rhesus)‐blood‐group‐antigen expression
16. Regarding the size of Rh proteins (letter)
17. The Rh polypeptide is a major fatty acid‐acylated erythrocyte membrane protein
18. null, human erythrocytes have an abnormal membrane phospholipid organization
19. Genetic basis of the Rh‐positive and Rh‐negative blood group polymorphism as determined by Southern analysis
20. Primary structure of human erythrocyte glycophorin A. Isolation and characterization of peptides and complete amino acid sequence
21. Structural organization of glycophorin A and B genes: glycophorin B gene evolved by homologous recombination at Alu repeat sequences
22. Isolation and characterization of human glycophorin A cDNA clones by a synthetic oligonucleotide approach: nucleotide sequence and mRNA structure
23. Molecular cloning of a human glycophorin B cDNA: nucleotide sequence and genomic relationship to glycophorin A
24. Structure of the 5′ flanking region of the gene encoding human glycophorin A and analysis of its multiple transcripts
25. Characterization of cDNA clones for human glycophorin A. Use for gene localization and for analysis of normal or glycophorin‐A‐deficient (Finnish type) genomic DNA
26. Isolation of cDNA clones for human erythrocyte membrane sialoglycoproteins α and δ
27. A single‐base change at a splice site in a β0‐thalassemic gene causes abnormal RNA splicing
28. Evidence for MN polymorphism in the precursor of glycophorins A and B (abstract)
29. Alteration of the genes for glycophorin A and B in glycophorin‐A‐deficient individuals
30. Studies on human red‐cell membrane glycophorin A and glycophorin B genes in glycophorin‐deficient individuals
31. Identification of human erythrocyte blood group antigens on decay‐accelerating factor (DAF) and an erythrocyte phenotype negative for DAF
32. Phosphatidylinositol‐linked proteins and paroxysmal nocturnal hemoglobinuria
33. Biochemistry of the glycosyl‐phosphatidylinositol membrane protein anchors
34. Decay‐accelerating factor: biochemistry, molecular biology, and function
35. Evidence that several high‐frequency human blood group antigens reside on phosphatidylinositol‐linked erythrocyte membrane proteins
36. The gene encoding decay‐accelerating factor (DAF) is located in the complement‐regulatory locus on the long arm of chromosome 1
37. Normal polymorphic variations and transcription of the decay accelerating factor gene in paroxysmal nocturnal hemoglobinuria cells
38. Cloning of decay‐accelerating factor suggests novel use of splicing to generate two proteins
39. Cloning and characterization of cDNAs encoding the complete sequence of decay‐accelerating factor of human complement
40. a by human platelet concentrates (letter)
41. Studies on the defect which causes absence of decay accelerating factor (DAF) from the peripheral blood cells of an individual with the Inab phenotype
42. a
43. a and a family with the Dr(a‐) phenotype in two generations
44. Localization of the human MHC‐linked complement genes between HLA‐B and HLA‐DR by using HLA mutant cell lines
45. A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2, and factor B
46. Statement on the nomenclature of human C4 allotypes
47. Inherited structural polymorphism of the fourth component of human complement
48. A molecular basis for the two locus model of human complement component C4
49. The structural basis of the multiple forms of human complement component C4
50. Localisation of Chido and Rodgers determinants to the C4d fragment of human C4
51. Structural basis of the polymorphism of human complement components C4A and C4B: gene site, reactivity and antigenicity
52. The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement C4
53. Substitution of a single amino acid (aspartic acid for histidine) converts the functional activity of human complement C4B to C4A
54. Genetics and polymorphism of the complement components
55. Polymorphism of the human complement C4 and steroid 21‐hydroxylase genes. Restriction fragment length polymorphisms revealing structural deletions, homoduplications, and size variants
56. Null alleles of human complement C4. Evidence for pseudogenes at the C4A locus and for gene conversion at the C4B locus
57. Restriction fragment analysis of non‐deleted complement C4 null genes suggests point mutations in C4A null alleles, but gene conversions in C4B null alleles
58. Cloning of cDNA for the major DNA‐binding protein of the erythroid lineage through expression in mammalian cells
59. Nuclear proteins that bind the human γ‐globin gene promoter: alterations in binding produced by point mutations associated with hereditary persistence of fetal hemoglobin
60. Structure and transcription of the mouse erythropoietin receptor gene
61. Expression of an erythroid transcription factor in megakaryocytic and mast cell lineages
62. The major human erythroid DNA‐binding protein (GF‐1): primary sequence and localization of the gene to the X chromosome